Pulmonary hypertension in sickle cell hemoglobinopathy: A clinicopathologic study of 20 cases

Human Pathology

Volumn 33, Issue 10, 2002, Pages 1037-1043

  Haque, Abida K ^a,b   Gokhale, Sumita ^a,b   Rampy, Bill A ^a,b   Adegboyega, Patrick ^a,b   Duarte, Alex ^a,b   Saldana, Mario J ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Lung pathology; Pulmonary hypertension; Sickle cell hemoglobinopathy

Indexed keywords

HEMOGLOBIN S;

ADULT; AGED; ARTERIOLE; ARTERY INTIMA PROLIFERATION; ARTICLE; AUTOPSY; CARDIOMEGALY; CLINICAL ARTICLE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ELECTROPHORESIS; FEMALE; HEMOCHROMATOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; MALE; MORTALITY; ONSET AGE; PULMONARY HYPERTENSION; SICKLE CELL TRAIT; SUDDEN DEATH; SYSTOLIC BLOOD PRESSURE; TRICUSPID VALVE REGURGITATION; VENULE;

EID: 0036802402     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2002.128059     Document Type: Article

References (34)

1. Minter KR, Gladwin MT: Pulmonary complications of sickle cell anemia. Am J Resp Crit Care Med; 164:2016-2019, 2001
2. Weil JV, Castro O, Malik AB, et al: Pathogenesis of lung disease in sickle hemoglobinopathies. Am Rev Resir Dis 148:249-256, 1993
3. Gokhale S, Adegboyega P, Veasey S, et al: Pulmonary changes in sickle cell hemoglobinopathy. An autopsy study. Mod Pathol 13:5A, 2000
4. Adedeji MO, Cespedes J, Allen K, et al: Pulmonary thrombotic arteriopathy in patients with sickle cell disease. Arch Pathol Lab Med 125:1436-1441, 2001
5. Heath D, Edwards JE: The pathology of hypertensive pulmonait vascular disease. A description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation 18:533-547, 1958
6. Wagenvoort CA: Grading of pulmonary vascular lesions - A reappraisal. Histopathology 5:595-598, 1981
7. Katzenstein ALA, Askin FB. Pulmonary hypertension and other vascular disorders. In Bennington JL (eds): Surgical Pathology of Non-Neoplastic Lung Disease, Ed 2. Philadelphia, PA, Saunders, 1990, pp 434-457.
8. Roberts WC: A simple histologic classification of pulmonary hypertension. Am J Cardiol 58:385-386, 1986
9. Agresti A: Categorical Data Analysis. New York, NY, Wiley, 1990
10. Elghetany MT, Davey FR: Erythrocytic disorders, in Davey FR, Henry JB (eds): Clinical Diagnosis and Management by Laboratory Methods, Ed 20. Philadelphia, PA, Saunders, 2001, pp 564-565
11. Yater WM, Hansman GH: Sickle cell anemia: A new cause of cor pulmonale. Am J Med Sci 191:474-484, 1936
12. Yoder L, Tabesh E, Taguchi JT: Primary pulmonary hypertension and sickle cell trait. Ohio State Med J 71:75-78, 1975
13. Collins FS, Orringer EP: Pulmonary hypertension and cor pulmonale in the sickle cell hemoglobinopathies. Am J Med 73:814-821, 1982
14. Sutton LL, Castro O, Cross DJ, et al: Pulmonary hypertension in sickle cell disease. Am J Cardiol 74:626-628, 1994
15. Aboubakr SE, Girgis RE, Swerdlow P: Pulmonary hypertension in sickle cell disease [abstract]. Am J Respir Crit Care Med 160:A144, 1999
16. Simmons BE, Santhanam V, Castaner A, et al: Sickle cell heart disease: Two-dimensional echo and doppler ultrasonographic findings in the hearts of adult patients with sickle cell anemia. Arch Intern Med 148:1526-1528, 1988
17. Platt OS, Brambilla DJ, Rosse WF, et al: Mortality in sickle cell disease: Life expectancy and risk factors for early death. New Engl J Med 330:1639-1644, 1994
18. Verresen D, De Backer W, Vermeire P: Pulmonary hypertension and sickle hemoglobinopathy [letter]. Chest 98:1042, 1990
19. Miller GJ, Serjeant GR: An assessment of lung volumes and gas transfer in sickle cell anemia. Thorax 26:309-315, 1971
20. Miller GJ, Saunders MJ, Richardson C, et al: Interpretation of lung function tests in the sickle cell hemoglobinopathies. Thorax 33:85-88, 1978
21. Femi-Pearse D, Gzioglo KM, Yu PN: Pulmonary function studies in sickle cell disease. J Appl Physiol 28:574-577, 1970
22. Serjeant GR: Pulmonary system, in Serjeant GR (ed). Sickle Cell Disease. NewYork, NY, Oxford University Press, 1985, pp 150-159
23. Ruttner JR, Bartschi JP, Niedermann R, et al: Plexogenic pulmonary arteriopathy and liver cirrhosis. Thorax 35:133-136, 1980
24. Molden D, Abraham JL: Pulmonary hypertension: Its association with hepatic cirrhosis and iron accumulation. Arch Pathol Lab Med 106:328-331, 1982
25. McDonnell PJ, Toye PA, Hutchins GM: Primary pulmonary hypertension and cirrhosis: Are they related? Am Rev Respir Dis 127:437-441, 1983
26. Cohen MD, Rubin LJ, Taylor WE, et al: Primary pulmonary hypertension: An unusual case associated with extrahepatic portal hypertension. Hepatology 3:588-592, 1983
27. Voelkel NF, Tuder RM: Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension. Eur Respir J 8:2129-2138, 1995
28. Resnick N, Collins T, Atkinson W, et al: Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear stress responsive element. Proc Natl Acad Sci U S A 90:4591-4595, 1993
29. Tuder RM, Flook B, Voelkel NF: Increased gene expression for VEGF and the VEGF receptor Kdr/Flk and Flt in lungs of chronically hypoxive rats. J Clin Inv 95:1798-1807, 1995
30. Chida M, Voelkel NF: Acute but not chronic hypoxia upregulates lung cyclo-oxygenase-2 gene via prostacylin. Am J Respir Cell Mol Biol 1994
31. Wang GL, Semenza GL: General involvement of hypoxia- inducible factor 1 in transcriptional response to hypoxia. Proc Nat Acad Sci U S A 90:4304-4308, 1993
32. Semenza GL, Wang GL: A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12:5447-5454, 1992
33. Voelkel NF, Cool C, Lee SD, et al: Primary pulmonary hypertension between inflammation and cancer. Chest 114:225S-230S, 1998
34. Mason NA, Springall DR, Burke M, et al: High expression of endothelial nitric oxide synthase in plexiform lesions of pulmonary hypertension. J Pathol 185:313-318, 1998